Vis enkel innførsel

dc.contributor.advisorKlingenberg, Claus
dc.contributor.authorJackola, Kristin Elise
dc.contributor.authorKaroliussen, Kristine Solstrand
dc.date.accessioned2024-05-27T06:40:39Z
dc.date.available2024-05-27T06:40:39Z
dc.date.issued2022-05-24
dc.description.abstract<p>Introduction: The association between respiratory support and lung disease is known. This study analysed the duration of different respiratory managements for preterm infants born before week 28 and between week 28-31 and preterm infants with BPD. Regional differences were also evaluated. <p>Materials and methods: a nationwide population-based registry study, and the data is gathered from Norwegian Neonatal Network. The data obtains all live-born premature infants born between gestation age 22-31 in the given period. A total of 5296 premature infants were included. <p>Results: A total of 1397 (85%) preterm infants born before week 28 received MV and 949 (26%) of those born between week 28-31. Among infants diagnosed with BPD 654 (92%) born before week 28 received MV and 246 (64%) born week 28-31. Infants born before 28 weeks and with BPD2 had the longest median duration on non-invasive respiratory support (p<0.001). For all other ventilation support managements, the infants with BPD3 born before 28 weeks had the longest median duration (MV p<0.001, conventional ventilation p=0.122, HFV p=0,089). West region had the shortest median duration on MV for infants born before week 28 (p<0.001) and the lowest number of infants with BPD2/3. <p>Conclusion: This study provides evidence that non-invasive respiratory support is the most used ventilation management for all preterm infants. There were notable trends for reduced duration of MV with decreasing severity of BPD. There are a few differences between the health regions.en_US
dc.identifier.urihttps://hdl.handle.net/10037/33620
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subject.courseIDMED-3950
dc.subjectPremature infantsen_US
dc.subjectLung diseasesen_US
dc.subjectBPDen_US
dc.subjectSteroids against BPDen_US
dc.subjectHealth regions in Norwayen_US
dc.titleRespiratory morbidity and therapy in very preterm infants – a population-based study from 2009-2018en_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)